An Open Non-Randomized Multicenter Phase II Trial to Evaluate the Efficacy and Safety of Tarceva in Combination With Capecitabine in Patients With Advanced Pancreatic Cancer.
Phase of Trial: Phase II
Latest Information Update: 20 Jun 2012
At a glance
- Drugs Capecitabine (Primary) ; Erlotinib (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- Acronyms XELTA
- 17 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Dec 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 09 Apr 2009 New trial record